Abstract: The invention relates to the use of an antimycotic agent and an epithelial cell or endothelial cell adhesion inhibitor for producing a combination drug for the topical treatment of Candida mycoses selected from vulvovaginal candidiasis, oropharyngeal candidiasis (oral thrush), diaper dermatitis (diaper thrush) and intertriginous (Candida) eczema.
Abstract: The invention relates to homogemcitabines of general formula (2), with the meanings for the substituents as given in claim 1, method for production thereof, use for the production of the active agent gemcitabin and the use thereof for the production of medicaments for the treatment of proliferative diseases. The invention further relates to novel intermediates, as used in the inventive method.
Type:
Application
Filed:
July 20, 2006
Publication date:
October 9, 2008
Applicant:
PHARMACON-FORSCHUNG UND BERATUNG GMBH
Inventors:
Christian R. Noe, Muhamed Jasic, Hermann Kollmann, Karmin Saadat
Abstract: L-aspartyl-L-thienylalanine methyl esters of the formula ##STR1## where A is a radical of the formula ##STR2## in which R can be H or CH.sub.3, a process for its preparation, and its use as sweetener.